Aarti Drugs Ltd. Conference Calls and Earnings Call Transcripts

Aarti Drugs Ltd.

16 May 2022

342.70

4.12%

Earnings Call

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find attached herewith transcript of Q4 FY22 Earning Conference call.

pdf

Aarti Drugs Ltd.

10 May 2022

342.70

4.12%

Earnings Call

AARTI DRUGS LTD. - 524348 - Recording Of Conference Call

BSE India

In continuation to our letter dated May 5, 2022 regarding intimation of Investors/ Analyst conference call on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company's website. This can be accessed via the following link. Link: https://www.aartidrugs.co.in/concalls-transcript/

pdf

Aarti Drugs Ltd.

02 Feb 2022

342.70

4.12%

Earnings Call for Q3FY22 of Aarti Drugs

Conference Call with Aarti Drugs Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.

audio

Aarti Drugs Ltd.

16 Nov 2021

342.70

4.12%

Earnings Call

Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company had attended the Investor Conference

pdf